x
ServiziMenu principaleHome
You are here: Home > Events > Future Events > 6th ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology
Print

Description

Chairs: A. Eniu, RO - C. Zielinski, AT
Host chair: E. Vrdoljak, HR
ESO Masterclass Coordinator: N. Pavlidis, GR


This residential programme has been designed for medical and clinical oncologists, who wish to improve their skills or those who are preparing for the national board or ESMO exam. The programme will expose participants to a full spectrum of issues in clinical and medical oncology from basic science to advanced knowledge of systemic therapy as well as in the multidisciplinary treatment approach. It is intended to cover all major topics of ESMO-ASCO curriculum on medical oncology. The programme focuses on cancer pathology and molecular biology, pharmacology of anti-cancer drugs and on frequent cancers such as breast, lung, gastro-intestinal, gynaecological and head and neck cancer. Spotlight sessions will provide inside on state of the art approaches in melanoma, sarcoma, thyroid cancer and on palliative care. Furthermore, practical training will be offered in the frame of clinical case presentations, prepared and presented by the participants and faculty for an interactive discussion. All participants will reside at the Masterclass venue and participation is mandatory throughout the course. At the end of each of the five days a learning self-assessment discussion with the chair of the course will be provided.

LEARNING OBJECTIVES
• To update the knowledge on basic science of clinical and medical oncology
• To enhance the competence and practical performance in systemic therapy of malignancies
• To enhance the competence and practical performance in multidisciplinary cancer care
• To update knowledge and get additional skills in supportive as well as palliative care
• To prepare for the board exam in clinical/medical oncology

MAIN TOPICS
• Cancer biology/pathology
• Cancer genetics
• Pharmacology of anti-cancer drugs
• Breast cancer
• Gastro-intestinal tumours
• Gynaecological tumours
• Head and neck cancers
• Lung cancer and mesothelioma
• Genito-urinary cancers
• Palliative and supportive care
• Haematological malignancies

The Eastern Europe
and Balkan Region Masterclass in
Medical Oncology is an
ESO-ESMO joint event

     

 

 

Faculty

FACULTY
C. Antoniotti, Azienda Ospedaliero-Universitaria Pisana, Pisa, IT
J. Beyer, University Hospital Zürich, CH
S. Bosnjak, Institute of Oncology and Radiology of Serbia, Belgrade, RS
E. Brain, Marie Curie Institute, Paris, FR
M.J. Cardoso, Champalimaud Cancer Center, Lisbon, PT
P.G. Casali, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
T. Cufer, University Clinic Golnik, Golnik, SI
A. Eniu, Cancer Institute « I. Chiricuta”, Cluj-Napoca, RO
F. B. Geara, American University of Beirut Medical Center, Beirut, LB
M. Halaska, Charles University and Faculty Hospital Kralovske Vinohrady, Prague, CZ
M.A. Hoda, Medical University Vienna, Vienna, AT
D. Jovanovic, Clinical Center of Serbia, Belgrade, RS
I. Kern, University Clinic Golnik, Golnik, SI
S. Martin Algarra, University Clinic of Navarra, Instituto de Investigación Sanitaria de Navarra, Pamplona, ES
D. Papamichael, Bank of Cyprus Oncology Centre, Nicosia, CY
N. Pavlidis, University Hospital of Ioannina, GR
R. Popescu, Hirslanden Klinik Aarau, CH
M. Porebiak, SWPS University of Social Sciences and Humanities, Warsaw, PL
C. Sessa, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
C. Sotiriou, Institut Jules Bordet, Brussels, BE
A. Stathis, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
S. Tomic, Clinical Institute of Pathology KBC Split, Split, HR
J.B. Vermorken, Antwerp University Hospital, Edegem, BE
D. Vrbanec, University Hospital Zagreb, Zagreb, HR
E. Vrdoljak, Clinical Hospital Split, Medical School Split, Split, HR
C. Zielinski, Comprehensive Cancer Center Vienna, Vienna, AT

General information

ORGANISING SECRETARIAT
Dolores Knupfer and Laura Richetti
European School of Oncology (ESO)
Piazza Indipendenza 2
6500 Bellinzona
ph +41 91 820 09 52
e-mail: dknupfer@eso.net - lrichetti@eso.net

CME ACCREDITATION AND CERTIFICATE
The 6th ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net
The programme has been granted up to 26 European CME credits (ECMEC) . Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme
Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.

The programme is furthermore accredited with 25 ESMO-MORA category 1 points.

Participants will receive their certificate of attendance via e-mail after the event on completion of the evaluation form.

INSURANCE
The organisers bear no responsibility for untoward events in relation to the participation in the event. Participants will be advised to take out their own personal and travel insurance coverage.


Application

IDEAL MASTERCLASS CANDIDATE
• Age between 30 and 40 years
• 2-3 years’ experience in oncology
• Involvement in scientific activities and clinical trials
• Fluency in English

PARTICIPATION
Admittance to the Masterclass is by competitive application. The successful applicants are granted free registration, full board, airport transfer to the course venue and accommodation in Split for the period 12-17 April 2019. Travel will be covered by the participants.
All participants will be expected to reside at the course venue and their full participation is compulsory throughout the course.

HOW TO APPLY
Interested oncologists should apply online (at the top of this page) providing the following documents:

• Letter describing motivation for attending the Masterclass
• Short CV (maximum 2 pages) with a list of publications (if the list of publication is not provided, it will be assumed that no articles have been published)
• Supporting letter from Head of Department/Mentor
• Abstract with proposed presentation of a clinical case relating to one of the main themes of the Masterclass (Breast Cancer, Gastro-intestinal cancers, Genito-urinary cancers, Gynaecological tumours, Sympton management of gynaecological tumours, Head and neck cancer, Lung and mesothelioma)

The abstract should be presented in the form of a grand-round clinical discussion rather than a publication report, and describe:

• Diagnostic considerations
• Treatment
• Outcome (follow-up)
• Up to three questions that the author proposes for discussion by the faculty and participants

Candidates should avoid the selection of very rare or unusual cases and try to find clinical situations more likely to be encountered in day to day practice.

ATTENDANCE TO THE MASTERCLASS IS BY APPLICATION ONLY
APPLICATION DEADLINE: 18 DECEMBER 2018

Before you start completing the online application form, please be sure you have all the requested files (CV, Motivation letter, Supporting letter, Professional experience template and Abstract template) ready to be uploaded to the system. Online applications will not be complete unless all the files are uploaded.

TEMPLATES
Download HERE your Professional experience template
•  Download HERE your Abstract template

Programme

12 April

17:00   Registration
17:30   Welcome address and general introduction
A. Eniu, RO - N. Pavlidis - GR, E. Vrdoljak, HR
18:05   Discussion
17:45   Access to care: an old/new issue? Global and Eastern European issues
A. Eniu, RO
18:35   Discussion
20:00   Dinner    

 

 13 April

CLINICAL SESSION GENITO-URINARY TUMOURS
Chairs: J. Beyer, CH - F.B. Geara, LB  
 9:00   Local therapy for prostate cancer
(surgery and radiotherapy)

S. Stojanovic-Rundic, RS
 9:20   Discussion
 9:30   Metastatic prostate cancer
J. Beyer, CH
 9:50   Discussion
 10:00   Testicular cancer
J. Beyer, CH
 10:20   Discussion   
 10:30   Systemic treatment of advanced renal cancer
M. Strijbos, BE
 11:50   Discussion
 11:00   Coffee break
11:30   Tumor board on genito-urinary tumours
Faculty
 12:00   Lunch
SPOTLIGHT SESSION 1
Chair:
N. Pavlidis, GR
 14:00   Sarcomas
P.G. Casali, IT
 14:20   Discussion
 14:30   GIST
P.G. Casali, IT
 14:50   Discussion
15:00   Coffee break
SPOTLIGHT SESSION 2
Chair:
N. Pavlidis, GR
15:30   IPOS lecture: Communication skills as first level psycho-social care
M. Porebiak, PL
15:55   Discussion
 16:10
-17:40
  PARTICIPANTS' CASE PRESENTATIONS
(3 groups in parallel, 15 cases)
A. Eniu, RO - R. Popescu, CH - N. Pavlidis, GR
 20:00   Dinner

 

 14 April

CLINICAL SESSION BREAST CANCER
Chairs: T. Cufer, SI - E. Vrdoljak, HR  
8:30   Breast cancer pathology and molecular biology
S. Tomic, HR
8:50   Discussion         
9:00   Optimal surgical management of breast cancer
M.J. Cardoso, PT
9:20   Discussion  
9:30   The role of radiotherapy in early and advanced BC
E. Vrdoljak, HR
9:50   Discussion
10:00   Coffee break
10:30   Optimal approach in locally advanced disease: ESO-ESMO ABC Guidelines
D. Vrbanec, HR
10:50   Discussion   
 11:00   Systemic treatment of luminal early and advanced breast cancer
A. Eniu, RO
 11:20   Discussion   
 11:30   Systemic treatment of HER2-positive early and advanced BC
T. Cufer, SI      
 11:50  
Discussion
12:00
  Systemic treatment of TN early and advanced BC
C. Sotiriou, BE
 12:20   Discussion
 13:00   Lunch
 14:30   Tumor board on breast cancer
Faculty
15:30   Coffee break
SPOTLIGHT SESSION 3
Chairs: E. Brain, FR - A. Stathis, CH
 16:00   Advances in the management of non-Hodgkin's lymphoma
A. Stathis, CH
 16:20   Discussion
 16:30   Management of cancer in the elderly
E. Brain, FR
 16:50   Discussion
 20:00   Offsite Dinner

 

 15 April

CLINICAL SESSION LUNG CANCER AND MESOTHELIOMA
Chairs: T. Cufer, SI - D. Jovanovic, RS  
9:00
  Lung cancer pathology and molecular biology
I. Kern, SI
9:20   Discussion         
9:30   Surgery for lung cancer and malignant pleural mesothelioma
M.A. Hoda, AT
10:00   Discussion   
10:10   Optimal management of N2 disease
D. Jovanovic, RS
10:30   Discussion
10:40   Coffee break
11:00   Chemotherapy and targeted agents in lung cancer (NSCLC and SCLC)
T. Cufer, SI
11:45   Discussion
11:55   Systemic managemant of mesothelioma
D. Jovanovic, RS
12:15
  Discussion 
12:25   Immune check point inhibitors: Immunologic background, indications and innovations C. Zielinski, AT
12:50   Discussion
13:00   Lunch
 14:00   Tumor board on lung cancer
Faculty
SPOTLIGHT SESSION 4
Chair: R. Popescu, CH  
 15:15   Systemic management of pancreatic cancer
R. Popescu, CH
15:35
  Discussion
 15:45   Palliative care
S. Bosnjak, RS
 16:05   Discussion
16:15   Supportive care
S.Bosnjak, RS
16:35   Discussion
 16:45   Coffee break
 17:15 - 18:30
  PARTICIPANTS' CASE PRESENTATIONS
(3 groups in parallel, 15 cases)
N. Pavlidis, GR - R. Popescu, CH - C. Zielinski, AT
 20:00   Dinner

 

 16 April

CLINICAL SESSION GASTROINTESTINAL TUMOURS 
Chairs: C. Antoniotti, IT - D. Papamichael, CY
8:30   Adjuvant/neoadjuvant systemic treatment of colorectal cancer
C. Antoniotti, IT
8:50   Discussion
9:00   Systemic treatment of advanced colorectal cancer
C. Antoniotti, IT
9:20   Discussion
9:30   Coffee break
10:00   Management of rectal cancer
D. Papamichael, CY
10:20   Discussion
10:30   Systemic treatment of advanced gastric cancer
D. Papamichael, CY
10:50   Discussion
11:00   Tumour board on gastro-intestinal tumours
C. Antoniotti, IT - D. Papamichael, CY
12:00   Lunch
CLINICAL SESSION GYNAECOLOGICAL TUMOURS
Chair: C. Sessa, CH
13:00   Screening of cervical cancer
C. Sessa, CH
13:30   Discussion
13:40   Role of surgery in gynaecological cancer
M. Halaska, CZ
14:10   Discussion
14:20   Systemic management of ovarian cancer
J.B. Vermorken, BE
14:50   Discussion
15:00   Systemic management of cervical and endometrial
C. Sessa, CH
15:40   Discussion
15:50   Coffee break
16:15   Tumor board on gynaecological tumours 
Faculty
CLINICAL SESSION HEAD AND NECK CANCERS
Chair: N. Pavlidis, GR
17:00   Therapeutic management of head and neck cancers
J.B. Vermorken, BE
17:30   Discussion
12:30   Tumour board on head and neck cancers
J.B. Vermorken, BE
19:00
  Departure from hotel
19:30   Off-site dinner

 

 17 April

SPOTLIGHT SESSION 5
Chair: S. Martin-Algarra, ES
9:00   Management of melanoma with immunotherapy and targeted treatment
S. Martin-Algarra, ES
9:20   Discussion
9:30   The diagnostic and therapeutic management of Cancer of Unknown Primary
N. Pavlidis, GR
10:00   Discussion
 10:10   Learning self-assessment test
Chairs
 11:00   Close
Chairs
 11:30   Standing lunch and departures

 

Follow us